Terbinafine resistance: A rising and worrisome specter
Steven Hainsworth, BAppSci, MMedSc, with Cheryl Guttman Krader For almost three decades, the allylamine antifungal drug terbinafine has been the first-line drug for treating dermatophyte infections, and it remains a reliable choice. However, dermatologists should be aware that terbinafine resistance is a real phenomenon that appears to be on the rise and spreading, said Steven […]